Cleveland Clinic Lerner Research Institute Logo
Cleveland Clinic Lerner Research Institute Logo
  • About
  • Science
    • Laboratories
    • Office of Research Development
    • Clinical & Translational Research
      Participating in Research
    • Departments
      Biomedical Engineering Cancer Biology Cardiovascular & Metabolic Sciences Florida Research & Innovation Center Genomic Medicine Immunotherapy & Precision Immuno-Oncology
      Infection Biology Inflammation & Immunity Neurosciences Ophthalmic Research Quantitative Health Sciences Translational Hematology & Oncology Research
    • Centers & Programs
      Advanced Musculoskeletal Imaging Angiogenesis Center Cardiovascular Diagnostics & Prevention Computational Life Sciences Consortium for Pain Genitourinary Malignancies Research Genome Center
      Microbiome & Human Health Musculoskeletal Research Northern Ohio Alcohol Center Pathogen & Human Health Research Populations Health Research Quantitative Metabolic Research Therapeutics Discovery
  • Core Services
    • Ohio
      3D Printing Bioimage AnalysisBioRobotics & Mechanical Testing Cell Culture Cleveland Clinic BioRepository Computational Oncology Platform Computing Services Discovery Lab Electron Microscopy Electronics Engineering
      Flow CytometryGenomic Medicine Institute Biorepository Genomics Glassware Histology Hybridoma Immunohistochemistry Immunomonitoring Lab Instrument Refurbishing & Repair Laboratory Diagnostic
      Lerner Research Institute BioRepository Light MicroscopyMechanical Prototyping Microbial Culturing & Engineering Microbial Sequencing & Analytics Resources Media Preparation Molecular Biotechnology Nitinol Polymer Proteomics & Metabolomics Therapeutics Discovery
    • Florida
      Bioinformatics
      Flow Cytometry
      Imaging
  • Education & Training
    • Graduate Programs Molecular Medicine PhD Program Postdoctoral Program
      Research Intensive Summer Experience (RISE) Undergraduate & High School Programs
  • News
  • Careers
    • Faculty Positions Research Associate & Project Staff Postdoctoral Positions Technical & Administrative Engagement & Belonging
  • Donate
  • Contact
  • About
  • Science
    • Scientific Programs
    • Laboratories
    • Office of Research Development
    • Clinical & Translational Research
      Participating in Research
    • Departments
      Biomedical Engineering Cancer Biology Cardiovascular & Metabolic Sciences Florida Research & Innovation Center Genomic Medicine Immunotherapy & Precision Immuno-Oncology
      Infection Biology Inflammation & Immunity Neurosciences Ophthalmic Research Quantitative Health Sciences Translational Hematology & Oncology Research
    • Centers & Programs
      Advanced Musculoskeletal Imaging Angiogenesis Center Cardiovascular Diagnostics & Prevention Computational Life Sciences Consortium for Pain Genitourinary Malignancies Research Genome Center
      Microbiome & Human Health Musculoskeletal Research Northern Ohio Alcohol Center Pathogen & Human Health Research Populations Health Research Quantitative Metabolic Research Therapeutics Discovery
  • Core Services
    • All Cores
    • Ohio
      3D Printing Bioimage Analysis BioRobotics & Mechanical Testing Cell Culture Cleveland Clinic BioRepository Computational Oncology Platform Computing Services Discovery Lab Electron Microscopy Electronics Engineering >
      Flow CytometryGenomic Medicine Institute BiorepositoryGenomics Glassware Histology Hybridoma Immunohistochemistry Immunomonitoring Lab Instrument Refurbishing & Repair Laboratory Diagnostic
      Lerner Research Institute BioRepository Light MicroscopyMechanical Prototyping Microbial Culturing & Engineering Microbial Sequencing & Analytics Resources Media Preparation Molecular Biotechnology Nitinol Polymer Proteomics & Metabolomics Therapeutics Discovery
    • Florida
      Bioinformatics
      Flow Cytometry
      Imaging
  • Education & Training
    • Research Education & Training Center
    • Graduate Programs Molecular Medicine PhD Program Postdoctoral Program
      Research Intensive Summer Experience (RISE) Undergraduate & High School Programs
  • News
  • Careers
    • Faculty Positions Research Associate & Project Staff Postdoctoral Positions Technical & AdministrativeEngagement & Belonging
  • Donate
  • Contact
  • Search

Zihua Gong Laboratory

❮Cancer Biology Zihua Gong Laboratory
  • Zihua Gong Laboratory
  • Principal Investigator
  • Research
  • Our Team
  • Publications
  • Careers
  • Research News

Principal Investigator

Zihua Gong Headshot

Zihua Gong, MD, PhD

Associate Staff
Location: Cleveland Clinic Main Campus

Research

Genomic instability caused by impaired DNA damage response and/or DNA repair is a triple-edged sword. On one hand, it is a driving force for tumorigenesis. On the other hand, defective DNA damage repair renders tumor cells more sensitive to DNA damaging agents, and thus allows for the use of radiation and many chemotherapeutic agents that induce DNA damage in clinic for cancer treatment. We are working on better understand the underlying mechanism on regulation of DNA repair pathway choice and resistance to PARP inhibition in BRCA1 mutant cancers, which are critical to develop new therapeutic strategies for cancer patients.


Biography

Coming soon. 


Education & Professional Highlights

Coming soon. 

Research

Research

Overview

Our laboratory is interested in understanding the molecular mechanisms underlying DNA repair pathway choice. BRCA1 and BRCA2 mutations are prevalent in familial breast and ovarian cancers. Cells with BRCA1 and BRCA2 mutations are exquisitely sensitive to PARP inhibitors (PARPi). However, treatment of BRCA mutant cancers with PARPi is not curative, and resistance to therapy is a major clinical problem. Our study investigates the mechanism on the competition and coordination of different DNA repair pathways, and uncovers key components in these pathways that we can explore to improve cancer therapy and overcome therapeutic resistance.

Our Team

Our Team

Publications

Selected Publications

View publications for Zihua Gong, MD, PhD
(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)


  1. Samsa WE, Zhang Z, Gong Z*.  CBFβ Regulates RUNX3 ADP-Ribosylation to Mediate Homologous Recombination Repair.  J Cell Physiol. 2025 Jan;240(1):e31503.
  2. Zhang Z, Samsa W, Gong Z*. NBS1 dePARylation by NUDT16 is critical for DNA double-strand break repair.  Mol Cell Biochem. 2024 Oct 23. doi: 10.1007/s11010-024-05140-8. Online ahead of print.  
  3. Zhang Z, Samsa W, Gong Z*. NUDT16 regulates CtIP PARylation to dictate homologous recombination repair. Nucleic Acids Res. 2024,  52(7):3761-3777. PMID: 38324469 
  4.  Dey G, Bharti R, Braley C, Alluri R, Esakov E, Crean-Tate K, McCrae K, Joehlin-Price A, Rose PG, Lathia J, Gong Z, Reizes O. LCK facilitates DNA damage repair by stabilizing RAD51 and BRCA1 in the nucleus of chemoresistant ovarian cancer. J Ovarian Res. 2023, 16(1):122. 
  5. Zhang Z, Samsa W, De Y, Zhang F, Reizes O, Almasan A, Gong Z*. HDGFRP3 interaction with 53BP1 promotes DNA double-strand break repair. Nucleic Acids Res. 2023, 51(5):2238-2256. 
  6. Feng H, Lu J, Song X, Thongkum A, Zhang F, Lou L, Reizes O, Almasan A, Gong Z*. CK2 kinase-mediated PHF8 phosphorylation controls TopBP1 stability to regulate DNA replication. Nucleic Acids Res. 2020 Nov 4;48(19):10940-10952 gkaa756. Online ahead of print. PMID: 33010150
  7. Zhang F, Lou L, Peng B, Song X, Reizes O, Almasan A, Gong Z*. Nudix hydrolase NUDT16 regulates 53BP1 protein by reversing 53BP1 ADP-ribosylation. Cancer Res. 2020; 80(5):999-1010. PMID: 31911551
  8. Dai Y, Zhang F, Wang L, Shan S, Gong Z*, Zhou Z*. Structural basis for shieldin complex subunit 3-mediated recruitment of the checkpoint protein REV7 during DNA double-strand break repair. J Biol Chem. 2020 Jan 3;295(1):250-262. (* co-corresponding author) PMID: 31796627
  9. Sharma A, Alswillah T, Kapoor I, Debjani P, Willard B, Summers MK, Gong Z, Almasan A.USP14 is a deubiquitinase for Ku70 and critical determinant of non-homologous end joining repair in autophagy and PTEN-deficient cells.  Nucleic Acids Res. 2020;48(2):736-747. PMID: 31740976
  10. Dai Y, Zhang A, Shan S, Gong Z*, Zhou, Z*. Structural basis for recognition of 53BP1 tandem Tudor domain by TIRR. Nature Communications. 2018 May 29; 9: 2123 (* co-corresponding author) PMID: 29844495
  11. Zhang Y, Shi J, Liu X, Feng L, Gong Z, Koppula P, Sirohi K, Li X, Wei Y, Lee H, Zhuang L, Chen G, Xiao ZD, Hung MC, Chen J, Huang P, Li W, Gan B. BAP1 links metabolic regulation of ferroptosis to tumour suppression. Nat Cell Biol. 2018 Oct; 20(10):1181-1192. PMID: 30202049
  12. Hu Y, Lin J, Fang H, Fang J, Li C, Chen W, Liu S, Ondrejka S, Gong Z, Reu F, Maciejewski J, Yi Q, Zhao JJ. Targeting the MALAT1/PARP1/LIG3 complex induces DNA damage and apoptosis in multiple myeloma. Leukemia. 2018 Oct; 32(10):2250-2262. PMID: 29632340
  13. Zhang A, Peng B, Huang P, Chen J*, Gong Z*. The p53-binding Protein 1-Tudor Interacting Repair Regulator Complex Participates in the DNA Damage Response. J Biol Chem. 2017, 292(16): 6461–6467. PMID: 28213517.  This paper is selected as “Editor Picks”, only top 2 percent of manuscripts is selected in a year.
  14. Chen Z, MyTran K, Tang MF, Wang W, Gong Z*, Chen J*. Proteomic Analysis Reveals a Novel MutS Partner Involved in Mismatch Repair Pathway. Molecular & Cellular Proteomics 2016, 15(4):1299-308. PMID: 27037360. (* co-corresponding author)
  15. Wang J, Aroumougame A, Lobrich M, Li Y, Chen J*, Gong Z*. PTIP associates with Artemis to dictate DNA repair pathway choice. Genes Dev 2014, 28 (24): 2693-8. PMID: 25512557.
  16. Xu S1, Li X1, Gong Z1, Wang W, Li Y, Nair BC, Piao H, Yang K, Wu G, Chen J. Proteomic analysis of the human CDK family reveals a novel CDK5 complex involved in cell growth and migration. Molecular & Cellular Proteomics 2014, 13(11):2986-3000. PMID: 25096995. (1 these authors contributed equally to this work)
  17.  Li Y, Fong KW, Tang M, Han X, Gong Z, Ma W, Hebert M, Songyang Z, Chen J. Fam118B, a novel component in Cajal bodies, is required for Cajal body formation, snRNP biogenesis and cell viability. J Cell Sci. 2014, 127(Pt 9):2029-39. 
  18. Wang J, Chen J*, Gong Z*. TopBP1 controls BLM protein level to maintain genome stability. Mol Cell. 2013 Dec 12;52(5):667-78. PMID: 24239288
  19. Leung CC, Sun L, Gong Z, Burkat M, Edwards R, Assmus M, Chen J, Glover JN. Structural insights into recognition of MDC1 by TopBP1 in DNA replication checkpoint control. Structure. 2013 Aug 6;21(8):1450-9. PMID: 23891287
  20. Wang J, Leung JW, Gong Z, Feng L, Shi X, Chen J. PHF6 regulates cell cycle progression by suppressing ribosomal RNA synthesis. J Biol Chem  2013, 288(5):3174-83. PMC3561539
  21. Wang J1, Gong Z1, Chen J. MDC1 collaborates with TopBP1 in DNA replication checkpoint control. J Cell Biol 2011, 193(2):267-73. (1 these authors contributed equally to this work). PMCID: PMC3080258.
  22. Gong Z, Chen J. E3 ligase RFWD3 participates in replication checkpoint control. J Biol Chem 2011, 286(25):2230
  23. Leung CC, Gong Z, Chen J, Glover JN. Molecular basis of BACH1/FANCJ recognition by TopBP1 in DNA replication checkpoint control. J Biol Chem 2011, 286(6):4292-301. PMCID: PMC3039391.
  24. Geunyeong P, Gong Z, Chen J, Kim JE. Characterization of the DOT1L network: Implications of diverse roles for DOT1L. Protein Journal 2010, 29(3): 213-223. PMID: 20431927
  25. Gong Z, Kim, JE, Leung, CC, Glover, JM, Chen J. BACH1/FANCJ acts with TopBP1 and participates early in DNA replication checkpoint control. Mol Cell 2010, 37(3):438-46. PMID: 20159562.
  26. Huang J1, Gong Z1, Ghosal G, Chen J. SOSS cooperates with RPA to maintain genomic stability.  Mol Cell 2009, 35(3):384-93. (1 these authors contributed equally to this work).  PMCID: PMC2756616.
  27. Gong Z, Cho YW, Kim JE, Ge K, Chen J. Accumulation of Pax2 Transactivation Domain Interaction Protein (PTIP) at Sites of DNA Breaks via RNF8-dependent Pathway Is Required for Cell Survival after DNA Damage. J Biol Chem 2009, 284(11):7284-93. PMCID: PMC2652327

Careers

Careers

Training at Lerner Research Institute

Our education and training programs offer hands-on experience at one of the nationʼs top hospitals. Travel, publish in high impact journals and collaborate with investigators to solve real-world biomedical research questions.

Learn More

Research News

Research News

...
Cleveland Clinic researcher receives $2 million to study DNA repair gene in breast cancer resistant to PARP inhibitors

Dr. Zihua Gong will investigate how the DNA repair gene nudt16 contributes to resistance to PARP inhibitor therapies in BRCA mutant breast cancers.



...
New Grants Boost Hereditary Breast and Ovarian Cancer Research

The grants will focus on continued studies using PARP inhibitors and newly identified DNA repair pathways to increase efficacy of cancer treatments.



Subscribe to get the latest research news in your inbox.

About Lerner

About Us Careers Contact Us Donate People Directory

Science

Clinical & Translational Research Core Services Departments, Centers & Programs Laboratories Research News

Education & Training

Graduate Programs Molecular Medicine PhD Program Postdoctoral Program RISE Program Undergraduate & High School Programs

Site Information & Policies

Search Site Site Map Privacy Policy Social Media Policy

9500 Euclid Avenue, Cleveland, Ohio 44195 | © 2025 Lerner Research Institute